CENTRE HOSPITALIER UNIVERSITAIRE - (Coördinator)
Country:
Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients
Full project pageOrganisations map overview
ASSOCIATION GENETHON
Country:
GOETEBORGS UNIVERSITET
Country:
HUMANITAS MIRASOLE SPA
Country:
ICON CLINICAL RESEARCH
Country:
ICON CLINICAL RESEARCH GMBH
Country:
ICON CLINICAL RESEARCH LIMITED
Country:
INSERM TRANSFERT SA
Country:
KING'S COLLEGE LONDON
Country:
MOTOR NEURONE DISEASE ASSOCIATION
Country:
QUEEN MARY UNIVERSITY OF LONDON
Country:
THE UNIVERSITY OF SHEFFIELD
Country:
THE UNIVERSITY OF SUSSEX
Country:
WGK CONSULTANCY LTD
Country: